BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 25683515)

  • 1. Quantitative pharmacokinetic analysis of prostate cancer DCE-MRI at 3T: comparison of two arterial input functions on cancer detection with digitized whole mount histopathological validation.
    Fennessy FM; Fedorov A; Penzkofer T; Kim KW; Hirsch MS; Vangel MG; Masry P; Flood TA; Chang MC; Tempany CM; Mulkern RV; Gupta SN
    Magn Reson Imaging; 2015 Sep; 33(7):886-94. PubMed ID: 25683515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of two methods for estimating DCE-MRI parameters via individual and cohort based AIFs in prostate cancer: a step towards practical implementation.
    Fedorov A; Fluckiger J; Ayers GD; Li X; Gupta SN; Tempany C; Mulkern R; Yankeelov TE; Fennessy FM
    Magn Reson Imaging; 2014 May; 32(4):321-9. PubMed ID: 24560287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic analysis of prostate cancer using independent component analysis.
    Mehrabian H; Da Rosa M; Haider MA; Martel AL
    Magn Reson Imaging; 2015 Dec; 33(10):1236-1245. PubMed ID: 26297961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of arterial input function selection on the accuracy of dynamic contrast-enhanced MRI quantitative analysis for the diagnosis of clinically significant prostate cancer.
    Azahaf M; Haberlay M; Betrouni N; Ernst O; Behal H; Duhamel A; Ouzzane A; Puech P
    J Magn Reson Imaging; 2016 Mar; 43(3):737-49. PubMed ID: 26303794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-specific pharmacokinetic parameter estimation on dynamic contrast-enhanced MRI of prostate: Preliminary evaluation of a novel AIF-free estimation method.
    Ginsburg SB; Taimen P; Merisaari H; Vainio P; Boström PJ; Aronen HJ; Jambor I; Madabhushi A
    J Magn Reson Imaging; 2016 Dec; 44(6):1405-1414. PubMed ID: 27285161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
    Mendichovszky IA; Cutajar M; Gordon I
    Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters.
    Ocak I; Bernardo M; Metzger G; Barrett T; Pinto P; Albert PS; Choyke PL
    AJR Am J Roentgenol; 2007 Oct; 189(4):849. PubMed ID: 17885055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of repeatability and treatment response in early phase clinical trials using DCE-MRI: comparison of parametric analysis using MR- and CT-derived arterial input functions.
    Rata M; Collins DJ; Darcy J; Messiou C; Tunariu N; Desouza N; Young H; Leach MO; Orton MR
    Eur Radiol; 2016 Jul; 26(7):1991-8. PubMed ID: 26385804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel AIF tracking method and comparison of DCE-MRI parameters using individual and population-based AIFs in human breast cancer.
    Li X; Welch EB; Arlinghaus LR; Chakravarthy AB; Xu L; Farley J; Loveless ME; Mayer IA; Kelley MC; Meszoely IM; Means-Powell JA; Abramson VG; Grau AM; Gore JC; Yankeelov TE
    Phys Med Biol; 2011 Sep; 56(17):5753-69. PubMed ID: 21841212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between population average and experimentally measured arterial input function in predicting biopsy results in prostate cancer.
    Meng R; Chang SD; Jones EC; Goldenberg SL; Kozlowski P
    Acad Radiol; 2010 Apr; 17(4):520-5. PubMed ID: 20074982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic contrast enhanced MRI of the prostate: comparison of gadobutrol and Gd-DTPA.
    Durmus T; Vollnberg B; Schwenke C; Kilic E; Huppertz A; Taupitz M; Franiel T
    Rofo; 2013 Sep; 185(9):862-8. PubMed ID: 23888476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimized Fast Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate: Effect of Sampling Duration on Pharmacokinetic Parameters.
    Othman AE; Falkner F; Martirosian P; Schraml C; Schwentner C; Nickel D; Nikolaou K; Notohamiprodjo M
    Invest Radiol; 2016 Feb; 51(2):106-12. PubMed ID: 26447494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic contrast-enhanced MRI parametric mapping using high spatiotemporal resolution Golden-angle RAdial Sparse Parallel MRI and iterative joint estimation of the arterial input function and pharmacokinetic parameters.
    Mazaheri Y; Kim N; Lakhman Y; Jafari R; Vargas A; Otazo R
    NMR Biomed; 2022 Jul; 35(7):e4718. PubMed ID: 35226774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcompartmentalization of extracellular extravascular space (EES) into permeability and leaky space with local arterial input function (AIF) results in improved discrimination between high- and low-grade glioma using dynamic contrast-enhanced (DCE) MRI.
    Sahoo P; Rathore RK; Awasthi R; Roy B; Verma S; Rathore D; Behari S; Husain M; Husain N; Pandey CM; Mohakud S; Gupta RK
    J Magn Reson Imaging; 2013 Sep; 38(3):677-88. PubMed ID: 23390002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automatic individual arterial input functions calculated from PCA outperform manual and population-averaged approaches for the pharmacokinetic modeling of DCE-MR images.
    Sanz-Requena R; Prats-Montalbán JM; Martí-Bonmatí L; Alberich-Bayarri Á; García-Martí G; Pérez R; Ferrer A
    J Magn Reson Imaging; 2015 Aug; 42(2):477-87. PubMed ID: 25410482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of model-based arterial input functions for dynamic contrast-enhanced MRI in tumor bearing rats.
    McGrath DM; Bradley DP; Tessier JL; Lacey T; Taylor CJ; Parker GJ
    Magn Reson Med; 2009 May; 61(5):1173-84. PubMed ID: 19253360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative diffusion-weighted imaging and dynamic contrast-enhanced characterization of the index lesion with multiparametric MRI in prostate cancer patients.
    Yuan Q; Costa DN; Sénégas J; Xi Y; Wiethoff AJ; Rofsky NM; Roehrborn C; Lenkinski RE; Pedrosa I
    J Magn Reson Imaging; 2017 Mar; 45(3):908-916. PubMed ID: 27442039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative sensitivities of DCE-MRI pharmacokinetic parameters to arterial input function (AIF) scaling.
    Li X; Cai Y; Moloney B; Chen Y; Huang W; Woods M; Coakley FV; Rooney WD; Garzotto MG; Springer CS
    J Magn Reson; 2016 Aug; 269():104-112. PubMed ID: 27288764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the arterial input function in dynamic contrast enhanced MRI by fitting the signal in the complex plane.
    Simonis FF; Sbrizzi A; Beld E; Lagendijk JJ; van den Berg CA
    Magn Reson Med; 2016 Oct; 76(4):1236-45. PubMed ID: 26525012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A data-driven approach to prostate cancer detection from dynamic contrast enhanced MRI.
    Haq NF; Kozlowski P; Jones EC; Chang SD; Goldenberg SL; Moradi M
    Comput Med Imaging Graph; 2015 Apr; 41():37-45. PubMed ID: 25060941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.